Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
出版年份 2022 全文链接
标题
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
作者
关键词
-
出版物
Clinical and Molecular Hepatology
Volume 28, Issue 3, Pages 425-472
出版商
The Korean Association for the Study of the Liver
发表日期
2022-07-07
DOI
10.3350/cmh.2022.0186
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Statin Use and Reduced Hepatocellular Carcinoma Risk in Patients with Non-alcoholic Fatty Liver Disease
- (2022) Biyao Zou et al. Clinical Gastroenterology and Hepatology
- Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders
- (2022) Donatien Serge Mbaga et al. PLoS One
- Effects of Branched-Chain Amino Acids on Parameters Evaluating Sarcopenia in Liver Cirrhosis: Systematic Review and Meta-Analysis
- (2022) Abdulrahman Ismaiel et al. Frontiers in Nutrition
- Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies
- (2021) Xiaofei Li et al. Frontiers in Medicine
- Diagnosis and Management of Hepatic Encephalopathy
- (2021) Marika Rudler et al. Clinics in Liver Disease
- Ursodeoxycholic acid impairs liver‐infiltrating T cell chemotaxis through IFNγ and CX3CL1 production in primary biliary cholangitis
- (2021) Shin Shimoyama et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog
- (2021) Vicki Wing-Ki Hui et al. Clinical and Translational Gastroenterology
- Systematic review with meta‐analysis: The effects of non‐steroidal anti‐inflammatory drugs and anti‐platelet therapy on the incidence and recurrence of hepatocellular carcinoma
- (2021) Regina Zi Hwei Tan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with network meta‐analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH
- (2021) Abdul M. Majzoub et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population‐based study
- (2021) Won‐Mook Choi et al. LIVER INTERNATIONAL
- KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
- (2021) Seong Hee Kang et al. Clinical and Molecular Hepatology
- L‐ornithine L ‐aspartate in acute treatment of severe hepatic encephalopathy: A double‐blind randomized controlled trial
- (2021) Arpan Jain et al. HEPATOLOGY
- Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives
- (2021) Alba Rocco et al. Frontiers in Cell and Developmental Biology
- Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis
- (2021) Kaneez Fatima et al. Clinics and Research in Hepatology and Gastroenterology
- Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study
- (2020) Yen-Hsiang Liao et al. BMC GASTROENTEROLOGY
- Synbiotic Alters Fecal Microbiomes, but not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Non-alcoholic Fatty Liver Disease
- (2020) Eleonora Scorletti et al. GASTROENTEROLOGY
- Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?
- (2020) Judith Aron-Wisnewsky et al. GASTROENTEROLOGY
- Association of Daily Aspirin Therapy with Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis C Virus Infection
- (2020) Teng-Yu Lee et al. Clinical Gastroenterology and Hepatology
- Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
- (2020) Tracey G. Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study
- (2020) Jung Gil Park et al. Nutrients
- Late Evening Snack with Branched-Chain Amino Acids Supplementation Improves Survival in Patients with Cirrhosis
- (2020) Tatsunori Hanai et al. Journal of Clinical Medicine
- Ursodeoxycholic acid alleviates nonalcoholic fatty liver disease by inhibiting apoptosis and improving autophagy via activating AMPK
- (2020) Pengbo Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial
- (2020) Muhammad Amjad Pervez et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease
- (2020) Jung Il Lee et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update
- (2020) Hiroshi Fukui Gut and Liver
- Systematic review with meta‐analysis: The effect of vitamin E supplementation in adult patients with non‐alcoholic fatty liver disease
- (2020) Andreas Vadarlis et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Anti-fibrotic effects of branched-chain amino acids on hepatic stellate cells
- (2020) Hae Lim Lee et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
- (2020) Na Young Lee et al. Clinical and Molecular Hepatology
- Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis
- (2020) Georgios Kalopitas et al. NUTRITION
- Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
- (2019) Teng-Yu Lee et al. JAMA Internal Medicine
- Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease
- (2019) Tracey G. Simon et al. Clinical Gastroenterology and Hepatology
- Treatment options for nonalcoholic fatty liver disease
- (2019) Amir Anushiravani et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection
- (2019) Shih-Hao Young et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Response by Ward et al to Letter Regarding Article, “Statin Toxicity: Mechanistic Insights and Clinical Implications”
- (2019) N.C. Ward et al. CIRCULATION RESEARCH
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease
- (2019) Sang Bong Ahn et al. Scientific Reports
- Aspirin targets P4HA2 through inhibiting NF-κB and LMCD1-AS1/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma
- (2019) Tianjiao Wang et al. EBioMedicine
- Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial
- (2019) Stefan Traussnigg et al. Lancet Gastroenterology & Hepatology
- Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
- (2019) Andrew M. Moon et al. Clinical Gastroenterology and Hepatology
- Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial
- (2019) Victor J. Navarro et al. PLoS One
- Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
- (2019) Meng-Wei Xiao et al. Gastroenterology Research and Practice
- Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota
- (2018) Aïda Bafeta et al. ANNALS OF INTERNAL MEDICINE
- Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
- (2018) Roger F. Butterworth et al. DIGESTIVE DISEASES
- A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial
- (2018) Journal of Gastrointestinal and Liver Diseases
- Correction of intrahepatic microcirculation disorders by L-ornithine-L-aspartate at the chronic liver diseases patients
- (2018) T. Ermolova et al. JOURNAL OF HEPATOLOGY
- Urea cycle dysregulation in non-alcoholic fatty liver disease
- (2018) Francesco De Chiara et al. JOURNAL OF HEPATOLOGY
- Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis
- (2018) Karen Louise Thomsen et al. MEDICAL HYPOTHESES
- Statins: pros and cons
- (2018) Iago Pinal-Fernandez et al. MEDICINA CLINICA
- Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
- (2018) Mario Masarone et al. Oxidative Medicine and Cellular Longevity
- Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
- (2018) Keith D. Lindor et al. HEPATOLOGY
- Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease
- (2018) David Porras et al. Frontiers in Physiology
- Association Between Aspirin Use and Risk of Hepatocellular Carcinoma
- (2018) Tracey G. Simon et al. JAMA Oncology
- Branched chain amino acids supplementation modulates TGF-β1/Smad signaling pathway and interleukins in CCl4 -induced liver fibrosis
- (2017) Naglaa F. Khedr et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment
- (2017) Minjong Lee et al. HEPATOLOGY
- Ursodeoxycholic acid attenuates experimental autoimmune arthritis by targeting Th17 and inducing pAMPK and transcriptional corepressor SMILE
- (2017) Eun-Jung Lee et al. IMMUNOLOGY LETTERS
- Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial
- (2017) Elina Manzhalii et al. Journal of Digestive Diseases
- The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups
- (2017) Shiv Chitturi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
- (2017) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients
- (2017) Michaela Mueller et al. LIVER INTERNATIONAL
- Silibinin Restores NAD+ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
- (2017) Federico Salomone et al. Nutrients
- Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model
- (2017) Kai Takegoshi et al. Oncotarget
- The Effect of Synbiotic Supplementation on Body Composition and Lipid Profile in Patients with NAFLD: A Randomized, Double Blind, Placebo-Controlled Clinical Trial Study
- (2017) Atefe Asgharian et al. Iranian Red Crescent Medical Journal
- A morphological method for ammonia detection in liver
- (2017) Virginia Gutiérrez-de-Juan et al. PLoS One
- Aspirin use is associated with lower indices of liver fibrosis among adults in the United States
- (2016) Z. Gordon Jiang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study
- (2016) Yi-Wen Huang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection
- (2016) Pei-Chang Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Ursodeoxycholic acid decreases age-related adiposity and inflammation in mice
- (2016) Ah-Reum Oh et al. BMB Reports
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) et al. DIABETOLOGIA
- Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C–Related Compensated Cirrhosis
- (2016) Arpan Mohanty et al. GASTROENTEROLOGY
- Gut microbiome and liver diseases
- (2016) Herbert Tilg et al. GUT
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Effects of in-hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease
- (2016) Shunji Koya et al. HEPATOLOGY RESEARCH
- Statins for Prevention of Cardiovascular Disease in Adults
- (2016) Roger Chou et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial
- (2016) Farzad Shidfar et al. Journal of Research in Medical Sciences
- Hepatotoxicity of statins and other lipid-lowering agents
- (2016) Einar S. Björnsson LIVER INTERNATIONAL
- Targeting Dysbiosis for the Treatment of Liver Disease
- (2016) Gobind Anand et al. SEMINARS IN LIVER DISEASE
- An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients
- (2016) Pathik Parikh et al. Saudi Journal of Gastroenterology
- Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor
- (2016) Ming Gu et al. Frontiers in Pharmacology
- NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project
- (2015) J. L. Petrick et al. Cancer Prevention Research
- A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
- (2015) Joseph L. Goldstein et al. CELL
- Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial
- (2015) Ji Cheol Bae et al. DIABETES CARE
- Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial
- (2015) Priscila Pollo-Flores et al. DIGESTIVE AND LIVER DISEASE
- Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES
- (2015) Adeel A. Butt et al. HEPATOLOGY
- Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
- (2015) Michaela Mueller et al. JOURNAL OF HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
- (2015) Tracey G. Simon et al. JOURNAL OF HEPATOLOGY
- Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
- (2015) John Chen Hsiang et al. JOURNAL OF HEPATOLOGY
- Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection
- (2015) Yao-Hsu Yang et al. JOURNAL OF HEPATOLOGY
- Sarcopenia impairs prognosis of patients with liver cirrhosis
- (2015) Tatsunori Hanai et al. NUTRITION
- Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome
- (2015) Konstantinos Kargiotis WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy of Lifestyle Changes in Subjects with Non-Alcoholic Liver Steatosis and Metabolic Syndrome May Be Improved with an Antioxidant Nutraceutical: A Controlled Clinical Study
- (2015) Gianpaolo Sorrentino et al. Drugs in research & development
- Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice
- (2015) Angela Moya-Pérez et al. PLoS One
- Association between aspirin use and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey
- (2014) H. Shen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
- (2014) Tannaz Eslamparast et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
- (2014) Monika Julia Wolf et al. CANCER CELL
- Statin Use in Patients with Cirrhosis: A Retrospective Cohort Study
- (2014) Sonal Kumar et al. DIGESTIVE DISEASES AND SCIENCES
- A systematic review of the safety of probiotics
- (2014) Tina Didari et al. Expert Opinion On Drug Safety
- Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
- (2014) Qing Jiang FREE RADICAL BIOLOGY AND MEDICINE
- Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial
- (2014) Radha K. Dhiman et al. GASTROENTEROLOGY
- Extrahepatic Platelet-Derived Growth Factor-β, Delivered by Platelets, Promotes Activation of Hepatic Stellate Cells and Biliary Fibrosis in Mice
- (2014) Shuhei Yoshida et al. GASTROENTEROLOGY
- Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease
- (2014) S. Nabavi et al. JOURNAL OF DAIRY SCIENCE
- Effect of carnitine-orotate complex on glucose metabolism and fatty liver: A double-blind, placebo-controlled study
- (2014) Eun Shil Hong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Pharmacological potential of tocotrienols: a review
- (2014) Haseeb Ahsan et al. Nutrition & Metabolism
- Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study
- (2014) Paola Stiuso et al. Oxidative Medicine and Cellular Longevity
- Protective Efficacy of Vitamins C and E on p,p′-DDT-Induced Cytotoxicity via the ROS-Mediated Mitochondrial Pathway and NF-κB/FasL Pathway
- (2014) Xiaoting Jin et al. PLoS One
- Glucocorticoid receptor-dependent immunomodulatory effect of ursodeoxycholic acid on liver lymphocytes in mice
- (2013) Toshimichi Takigawa et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
- (2013) Jiayin Yao et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial
- (2013) Manish Kumar Lunia et al. Clinical Gastroenterology and Hepatology
- Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway
- (2013) Yongxiang Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Oral Branched-Chain Amino Acids Have a Beneficial Effect on Manifestations of Hepatic Encephalopathy in a Systematic Review with Meta-Analyses of Randomized Controlled Trials
- (2013) Lise L. Gluud et al. JOURNAL OF NUTRITION
- Branched-chain amino acids and muscle ammonia detoxification in cirrhosis
- (2013) Gitte Dam et al. METABOLIC BRAIN DISEASE
- Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial
- (2013) Enrico Magosso et al. Nutrition Journal
- Alterations in Sulfur Amino Acid Metabolism in Mice Treated with Silymarin: A Novel Mechanism of Its Action Involved in Enhancement of the Antioxidant Defense in Liver
- (2013) Do Kwon et al. PLANTA MEDICA
- Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis
- (2013) Jung Hoon Cha et al. PLoS One
- Lipopolysaccharide Causes an Increase in Intestinal Tight Junction Permeability in Vitro and in Vivo by Inducing Enterocyte Membrane Expression and Localization of TLR-4 and CD14
- (2012) Shuhong Guo et al. AMERICAN JOURNAL OF PATHOLOGY
- Ursodeoxycholic acid stimulates the formation of the bile canalicular network
- (2012) Yuki Ikebuchi et al. BIOCHEMICAL PHARMACOLOGY
- Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial
- (2012) Mostafa Yakoot et al. BMC GASTROENTEROLOGY
- Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non- Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study
- (2012) Ali Akbar Hajiaghamohammadi et al. Hepatitis Monthly
- Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
- (2012) Takashi Nakahara et al. HEPATOLOGY RESEARCH
- Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cells
- (2012) MINA KIM et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy
- (2012) Michael W. Fried JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial–stellate cell deactivation induced by statins
- (2012) Giusi Marrone et al. JOURNAL OF HEPATOLOGY
- miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease
- (2012) Rui E. Castro et al. JOURNAL OF HEPATOLOGY
- Beneficial effect of branched-chain amino acid supplementation on glycemic control in chronic hepatitis C patients with insulin resistance: Implications for type 2 diabetes
- (2012) Yumie Takeshita et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Early administration of branched-chain amino acid granules
- (2012) Toru Ishikawa WORLD JOURNAL OF GASTROENTEROLOGY
- Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of action
- (2012) Raoul Poupon Clinics and Research in Hepatology and Gastroenterology
- Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study
- (2011) Iñigo Les et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications
- (2011) Marcelo G. Roma et al. CLINICAL SCIENCE
- Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
- (2011) Michele Malaguarnera et al. DIGESTIVE DISEASES AND SCIENCES
- Effects of late evening snack including branched-chain amino acid on the function of hepatic parenchymal cells in patients with liver cirrhosis
- (2011) Chizu Koreeda et al. HEPATOLOGY RESEARCH
- Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
- (2011) Hideyuki Hyogo et al. HEPATOLOGY RESEARCH
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antiapoptotic effect of DDB against hepatic ischemia-reperfusion injury
- (2011) Alshaymaa A. El-Bahy et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction
- (2011) Dae Won Jun et al. LIVER INTERNATIONAL
- Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis
- (2010) N. Beraza et al. GUT
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
- (2010) Ulrich F. H. Leuschner et al. HEPATOLOGY
- Effect of an oral branched chain amino acid-enriched snack in cirrhotic patients with sleep disturbance
- (2010) Tatsuki Ichikawa et al. HEPATOLOGY RESEARCH
- Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK
- (2010) Relja INTERNATIONAL JOURNAL OF ONCOLOGY
- Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver
- (2010) Nobito Higuchi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
- (2009) Juan G. Abraldes et al. GASTROENTEROLOGY
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
- (2009) P. D. Cani et al. GUT
- Clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study
- (2009) Peter Jepsen et al. HEPATOLOGY
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
- (2009) Marco Trappoliere et al. JOURNAL OF HEPATOLOGY
- Bile acids: regulation of apoptosis by ursodeoxycholic acid
- (2009) Joana D. Amaral et al. JOURNAL OF LIPID RESEARCH
- Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis
- (2009) Maria Luisa Balmer et al. LIVER INTERNATIONAL
- A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: Validation using prognostic markers for pre-liver transplant status
- (2009) Etsushi Kawamura et al. LIVER TRANSPLANTATION
- Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice
- (2008) Kosuke Okada et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
- (2008) Peter Ferenci et al. GASTROENTEROLOGY
- 8-Hydroxy-2′-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection
- (2008) Makoto Chuma et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
- (2008) Hideyuki Hyogo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
- (2008) R. Saller et al. FORSCHENDE KOMPLEMENTARMEDIZIN
- Localization of polypyrimidine-tract-binding protein is involved in the regulation of albumin synthesis by branched-chain amino acids in HepG2 cells
- (2007) Masashi Kuwahata et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started